Bfsg, LLC Mirati Therapeutics, Inc. Transaction History

Bfsg, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$0.0 - $59.28 $0 - $2,904	-49 Closed	0 $0
Q4 2023 Feb 01, 2024	BUY	$41.99 - $62.38 $2,057 - $3,056	49 New	49 $2,000
Q1 2021 Apr 26, 2021	SELL	$158.92 - $221.61 $463,410 - $646,214	-2,916 Closed	0 $0
Q4 2020 Jan 26, 2021	BUY	$162.05 - $240.27 $24,469 - $36,280	151 Added 5.46%	2,916 $640,000
Q3 2020 Nov 04, 2020	BUY	$113.26 - $167.27 $3,171 - $4,683	28 Added 1.02%	2,765 $459,000
Q2 2020 Jul 22, 2020	BUY	$72.01 - $120.39 $197,091 - $329,507	2,737 New	2,737 $312,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Bfsg, LLC, based on Form 13F filings with the SEC.

Stay updated on Bfsg, LLC with notifications on news.